Sustained elevated blood pressure can increase a patient’s risk for both aortic valve stenosis and aortic regurgitation, according to an analysis of 5.4 million non-CVD patients in the U.K.
A wearable ultrasound patch tracks blood pressure in a deep artery or vein. (Photo courtesy of Nature Biomedical Engineering).
Source
Chonghe Wang/Nature Biomedical Engineering
Copyright
Chonghe Wang/Nature Biomedical Engineering
Scientists have developed a wearable ultrasound device to measure central blood pressure (BP). It performed as well as a current noninvasive technique upon testing, according to a press release.
Carcinogen-containing valsartan products that were recalled in about two dozen countries over the past few months didn’t significantly raise cancer risk in the short term, according to a Danish registry study published online Sept. 12 in The BMJ.
As extreme weather hits the East Coast this weekend, residents are stocking up on nonperishables, buying batteries in bulk and boarding up windows. But storm preparation looks a little different for diabetics, who are forced to consider their medical needs weeks in advance, Everyday Health reports.
Minneapolis, MN—September 13, 2018—Researchers at the Minneapolis Heart Institute Foundation®(MHIF) enrolled their first patient in the TVINCITIES study (aorTic Valve dIsease aNd raCIal dispariTIES). This study is an example of physician-initiated research conducted at MHIF and is inspired and led by Mario Gössl, MD, PhD, co-chair, MHIF Valve Science Center, and MHIF researcher.
The concept of “time in range” has been used in warfarin monitoring and glycemic management for diabetic patients, but why hasn't it caught on as a useful metric in controlling hypertension?
Cerner and Duke Clinical Research Institute have teamed up to develop a new CVD risk calculator app, the companies announced late this summer—a move they hope will improve shared decision-making between physicians and their patients.
Medicaid expansion under the Affordable Care Act (ACA) failed to improve access to care for minorities and low-income patients with complex surgical needs, researchers reported in the Sept. 13 online edition of the Journal of the American College of Surgeons.
Gregg W. Stone, MD, had the unenviable task of condensing the 255-page agenda for next weekend’s Transcatheter Cardiovascular Therapeutics (TCT) meeting into a handful of highlights during a 12-minute media briefing on Thursday, Sept. 13.
Three decades after the first Transcatheter Cardiovascular Therapeutics conference, TCT.18’s organizers are moving “toward a more practical approach,” says Cardiovascular Research Foundation CEO Juan Granada, MD.
